Tetra-o-methyl nordihydroguaiaretic acid and Temozolomide work synergistically on Glioblastoma Multiforme tumors

Embargo until
Date
2014-04-10
Journal Title
Journal ISSN
Volume Title
Publisher
Johns Hopkins University
Abstract
Glioblastoma multiforme (GBM) is a grade IV astrocytoma and one of the most malignant brain tumors. GBM responds poorly to the current treatment methods, temozolomide (TMZ) and radiation. Tetra-O-methyl-nordihydroguaiaretic acid (M4N), a global transcription repressor of genes, is potent when used on GBM cell lines. Here, we investigate the effects of M4N in combination with TMZ on GBM cell lines. Cell proliferation measurements and drug combination analyses using different schedules of administration were performed on GBM cell lines. We found that M4N worked synergistically with TMZ to decrease tumor cell proliferation. M4N also induced apoptotic cell death, and our results suggest future clinical applications of M4N in combination with TMZ for GBM treatment.
Description
Keywords
Glioblastoma multiforme, tetra-O-methyl nordihydroguaiaretic acid
Citation